Gualandi E, Ravani A, Berto A, Burdo S, Trevisi P, Ferlini A, Martini A, Calzolari E
Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Genetica Medica, Università di Ferrara, Italy.
Acta Otolaryngol Suppl. 2004 May(552):29-34. doi: 10.1080/03655230410017166.
Molecular screening for GJB2 (connexin 26) mutations represents the standard diagnostic approach for the genotype definition of non-syndromic deafness. Nevertheless, a single GJB2 pathogenic mutation is detectable in a relevant number of cases, therefore failing to explain the phenotype. We aimed at assessing the occurrence of the recently described del(GIB6-D13S1830) mutation, occurring in the connexin 30 gene, in a group of Italian hearing-impaired patients carrying a single GJB2 mutated allele. A total of 59 non-syndromic hearing loss (NSHL) patients were screened for GJB2 mutations. Among these, nine NSHL patients were found to be heterozygous for a single GJB2 mutation. These patients, heterozygotes for different GJB2 mutated alleles (35delG, L90P, M34T, V153I), together with 11 additional 35delG/neg cases previously described, were studied for the presence of the del(GIB6-D13S1830) mutation. Two double heterozygotes del(GIB6-D13S1830)/35delG were identified. In both cases the degree of hearing loss was profound. Furthermore, GJB2 molecular screening led to the identification of a novel change (T55G) occurring in compound heterozygosity with the V37I mutation. In conclusion, our data suggest a significant frequency of del(GIB6-D13S1830) mutation in Italian hearing-impaired subjects (10% of unexplained GJB2 heterozygotes) similar to that reported in other European countries.
GJB2(连接蛋白26)突变的分子筛查是确定非综合征性耳聋基因型的标准诊断方法。然而,在相当数量的病例中只能检测到单一的GJB2致病突变,因此无法解释其表型。我们旨在评估在一组携带单一GJB2突变等位基因的意大利听力受损患者中,连接蛋白30基因中最近描述的del(GIB6-D13S1830)突变的发生率。共对59例非综合征性听力损失(NSHL)患者进行了GJB2突变筛查。其中,9例NSHL患者被发现为单一GJB2突变的杂合子。这些患者为不同GJB2突变等位基因(35delG、L90P、M34T、V153I)的杂合子,连同之前描述的另外11例35delG/阴性病例,研究了del(GIB6-D13S1830)突变的存在情况。鉴定出2例del(GIB6-D13S1830)/35delG双杂合子。在这两个病例中,听力损失程度均为重度。此外,GJB2分子筛查还发现了一个与V37I突变复合杂合出现的新变化(T55G)。总之,我们的数据表明,意大利听力受损受试者中del(GIB6-D13S1830)突变的频率较高(占无法解释的GJB2杂合子的10%),与其他欧洲国家报道的相似。